Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
A Herpes Simplex Virus-Derived Replicative Vector Expressing LIF Limits Experimental Demyelinating Disease and Modulates Autoimmunity.
The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P₁) and hypertension (S1P₃) in rat.
A Network Meta-Analysis of Efficacy and Evaluation of Safety of Subcutaneous Pegylated Interferon Beta-1a versus Other Injectable Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis.
Multiple sclerosis and progressive resistance training: a systematic review.
Normal outcome of pregnancy with ongoing treatment with natalizumab.
The effects of massage therapy on multiple sclerosis patients' quality of life and leg function.
Demyelination: the role of reactive oxygen and nitrogen species.
Santhera enters agreement with Columbia University to investigate additional potential of Catena® in MELAS
Recombinant T Cell Receptor Ligands Improve Outcome After Experimental Cerebral Ischemia.
Visual Functional and Histopathological Correlation in Experimental Autoimmune Optic Neuritis.
Tumefactive multiple sclerosis requiring emergent biopsy and histological investigation to confirm the diagnosis: a case report.
An observational study to assess persistence, adherence, quality of life, and treatment satisfaction in patients beginning therapy with the Avonex® PEN™ (PERSIST)
Cortical lesion load associates with progression of disability in multiple sclerosis.
The little compound that could: how phenytoin changed drug discovery and development.
Frequency of Comorbidities and Their Association with Clinical Disability and Relapse in Multiple Sclerosis.
Memory rehabilitation for people with multiple sclerosis.
Vitamin D and multiple sclerosis: a critical review and recommendations on treatment.
Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects with Multiple Sclerosis
Physiopathology of symptoms and signs in multiple sclerosis.
Dispositional optimism is unidimensional or bidimensional? The Portuguese revised Life Orientation Test.
Bullous pemphigoid in a patient with multiple sclerosis being treated with human immunoglobulin.
Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis.
Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis.
Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS) (ALLEGRO)
Ophthalmic Evaluations in Clinical Studies of Fingolimod (FTY720) in Multiple Sclerosis.
Pages
« first
‹ previous
…
105
106
107
108
109
110
111
112
113
…
next ›
last »